Special Issue "Big Data and Precision Medicine Series I: Lung Cancer Early Diagnosis"
Deadline for manuscript submissions: closed (31 December 2018)
Lung cancer is the leading cause of cancer-related deaths and patients’ survival is directly correlated to disease stage. Therefore, it is mandatory to adopt a screening strategy that embraces, not only the population at risk, but improve overall survival in high risk populations of asymptomatic patients. Today, the concept of tumor has been remodeled and it has been defined as a disease that has its own genetic, biological and metabolic identity and with this new awareness, new screening methods should base. The analysis of new biomarkers (i.e., volatile organic compounds, microRNA-test and urine analysis) associated with a high specificity of new screening methods, that are non-invasive, safety, inexpensive and simple to perform, could allow a non-invasive approach that can determine a big change in the early diagnosis of cancer and survival rate. Please join us in presenting this Special Issue on the state-of-the-art research currently being performed on lung cancer screening and early diagnosis to gather our effort in order to get, as soon as possible, an early and effective diagnosis of lung cancer.Dr. Gasparri Roberto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Lung cancer
- Early diagnosis
- Volatile organic compounds